MYL Share Price

Open 40.28 Change Price %
High 41.27 1 Day -0.64 -1.54
Low 40.25 1 Week -1.21 -2.87
Close 40.96 1 Month -1.48 -3.49
Volume 24463423 1 Year -4.92 -10.72
52 Week High 50.40
52 Week Low 33.60
MYL Important Levels
Resistance 2 41.91
Resistance 1 41.52
Pivot 40.83
Support 1 40.40
Support 2 40.01
NASDAQ USA Most Active Stocks
MU 28.43 7.40%
MU 28.43 7.40%
MU 28.43 7.40%
FNFG 10.18 -0.20%
FTR 2.09 7.73%
FTR 2.09 7.73%
ASTI 0.00 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
PGRX 0.06 200.00%
AMCF 0.10 100.00%
VALV 0.04 100.00%
LOCM 0.09 50.00%
BGMD 0.08 33.33%
ESMC 0.12 33.33%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Mylan Inc. (NASDAQ: MYL)

MYL Technical Analysis 1.5
As on 24th Mar 2017 MYL Share Price closed @ 40.96 and we RECOMMEND Sell for LONG-TERM with Stoploss of 41.23 & Buy for SHORT-TERM with Stoploss of 40.33 we also expect STOCK to react on Following IMPORTANT LEVELS.
MYL Target for March
1st Target up-side 44.37
2nd Target up-side 46.14
3rd Target up-side 47.91
1st Target down-side 39.33
2nd Target down-side 37.56
3rd Target down-side 35.79
MYL Other Details
Segment EQ
Market Capital 10603874304.00
Sector Consumer Durables Major Pharmaceuticals
Industry
Offical website
MYL Address
MYL
N/A
MYL Latest News
Interactive Technical Analysis Chart Mylan Inc. ( MYL NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Mylan Inc.
MYL Business Profile
Mylan Inc. (Mylan) is a fully integrated global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan has two segments:Generics and Specialty. Its generic pharmaceutical business is conducted primarily in the United States and Canada (collectively, North America); Europe, the Middle East, and Africa (collectively, EMEA); and India, Australia, Japan and New Zealand (collectively, Asia Pacific). Its API business is conducted through Mylan Laboratories Limited (Mylan India), which is included within the Asia Pacific region in its Generics Segment. The Company's pharmaceutical business is conducted by Mylan Specialty L.P. (Mylan Specialty). Mylan provides products to customers in approximately 140 countries and territories. In December 2013, In December 2013, the Company announced that it has completed the acquisition of the Agila injectables businesses from Strides Arcolab Ltd.